Connect with us

Hi, what are you looking for?

Economy

COVID-19 vaccination drive may start next week

By Kyle Aristophere T. Atienza, Reporter

FILIPINOS on the government’s priority list may get vaccinated against the coronavirus as early as next week as the government takes delivery of 600,000 vaccine doses donated by China on Sunday, according to the presidential palace.

“Three more nights and the vaccines will be here,” presidential spokesman Herminio “Harry” L. Roque, Jr. told a televised news briefing on Thursday.

President Rodrigo R. Duterte will welcome the arrival of the vaccines made by Chinese drug maker Sinovac Biotech Ltd., he said.

Sinovac General Manager Helen Yang on Wednesday said the vaccines were being prepared for delivery to the Philippines.

Of the initial batch of vaccines, about 100,000 will be used to immunize soldiers. The rest will be used to inoculate people on the priority list including medical frontliners.

The Department of Health (DoH) and the National Task Force Against the Coronavirus said in a joint statement details of how the vaccines would be distributed were still being discussed. An inter-agency task force would approve the plan, they added.

Mr. Roque said the President had used Philippine friendship with China to get early access to COVID-19 vaccines.

Sinovac’s CoronaVac is one of the frontrunners in the vaccine race, along with those developed by British drug maker AstraZeneca Plc, Russia’s Gameleya National Center of Epidemiology and Microbiology, and America’s Pfizer, Inc., Moderna, Inc. and  Johnson & Johnson.

TALLY
The Department of Health (DoH) reported 2,269 coronavirus infections on Thursday, bringing the total to 568,680.

The death toll rose by 72 to 12,201, while recoveries increased by 738 to 524,042, it said in a bulletin.

There were 32,437 active cases, 88.5% of which were mild, 6.1% did not show symptoms, 2.4% were critical, 2.3% were severe, and 0.78% were moderate.

The Health department said eight duplicates and one case found to be negative had been removed from the tally. Twelve recovered cases were reclassified as deaths.

Three laboratories failed to submit their data on Feb. 24, it said.

More than 8.1 million Filipinos have been tested for the coronavirus as of Feb. 23, according to DoH’s tracker website.

The coronavirus has sickened more than 113.1 million and killed more than 2.5 million people worldwide, according to the Worldometers website, citing various sources including data from the World Health Organization.

More than 88.7 million people have recovered, it said.

LESS EFFECTIVE
Senator Francis N. Pangilinan earlier urged the Health department to cancel the purchase of Sinovac’s CoronaVac, which he said is six times more expensive than AstraZeneca and less effective.

Food and Drug Administration (FDA) Director General Rolando Enrique D. Domingo earlier said the Chinese shot was not recommended for medical frontliners since its efficacy only reached 50.4% for their class based on trials in Turkey.

The efficacy of Sinovac ranged from 65.3% to 91.2% in patients aged 18 to 59 years based on trials in Indonesia. AstraZeneca has a 70% efficacy based on trials in Brazil and the United Kingdom.

Health professionals are not barred from taking Sinovac vaccines, Mr. Roque said, citing Mr. Domingo. “If they want it, they can have it. They won’t be taken out of the priority list.”

At the same briefing, Philippine General Hospital Director Gap Legazpi said their medical workers were ready to receive the Sinovac shots.

“Whatever vaccine comes, we should welcome it because it will make a difference in helping control the spread of this infection,” he said.

“We are not the last country to receive the vaccine,” Mr. Roque said. He added that had the government insisted on buying Western brands, it would have waited longer.

Vaccine czar Carlito G. Galvez, Jr. this week said only 5.1 million vaccine doses would arrive in the country this quarter.

Mr. Galvez earlier said the Philippines had secured about 10 million doses of coronavirus vaccines under a global initiative for equal access, most of which were from  AstraZeneca

and Pfizer.

The country, however, had a rough time dealing with drug makers seeking blanket protection from potential lawsuits, he said.

The Senate and House of Representatives have passed a bill creating a 500-million indemnification fund that will be used to compensate patients who may get sick from vaccines.

Under the measure, manufacturers won’t be liable for vaccine-related injuries. The National Government will assume responsibility for the emergency use of the vaccines.

The bill has been submitted for Mr. Duterte’s signature.

Mr. Galvez earlier said the lack of an indemnification plan had hindered the delivery of the first 117,000 doses of Pfizer vaccines under the Word Health Organization-led COVID-19 Vaccines Global Access (COVAX) facility.

About 24.1 million vaccine doses would come in the second quarter, Mr. Galvez told an online news briefing on Wednesday night. More vaccines under the COVAX facility will arrive in the second half, he added.

Mr. Galvez said the country was in talks with the United Kingdom, China, Russia and India to get more vaccine shots and ensure early delivery.

The country this week had a marathon meeting with Moderna to finetune the “language of the supply agreement,” he said.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Investing

Lowering VAT charges on fuel may be politically attractive but is not good news for those who will struggle the most, say leading tax...

Investing

An estimated 3 per cent of the workforce was signed off in late December and a fifth of businesses reported increased cancellations amid the...

Investing

Mark Zuckerberg could be forced to pay most British Facebook users about £50 each if a landmark legal action alleging that the site abused...

Investing

France has reopened its borders to British tourists after ministers in Paris eased restrictions on non-essential travel. From this morning, Britons travelling to the...

Investing

People struck down with the Omicron variant of the coronavirus are buying so much paracetamol that supplies are running low in many shops. Official...

Investing

Covid Passports are to be abandoned within days after Sajid Javid effectively killed off the policy. The health secretary has concluded that Covid-19 certification...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.